Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer.

Nagaprashantha LD, Singhal J, Li H, Warden C, Liu X, Horne D, Awasthi S, Salgia R, Singhal SS.

Oncotarget. 2018 Apr 6;9(26):18053-18068. doi: 10.18632/oncotarget.24720. eCollection 2018 Apr 6.

2.

Oxidative stress and dietary phytochemicals: Role in cancer chemoprevention and treatment.

Chikara S, Nagaprashantha LD, Singhal J, Horne D, Awasthi S, Singhal SS.

Cancer Lett. 2018 Jan 28;413:122-134. doi: 10.1016/j.canlet.2017.11.002. Epub 2017 Nov 4. Review.

PMID:
29113871
3.

2'-Hydroxyflavanone: A novel strategy for targeting breast cancer.

Singhal J, Nagaprashantha L, Chikara S, Awasthi S, Horne D, Singhal SS.

Oncotarget. 2017 Aug 24;8(43):75025-75037. doi: 10.18632/oncotarget.20499. eCollection 2017 Sep 26.

4.

RLIP76 Inhibition: A Promising Developmental Therapy for Neuroblastoma.

Singhal SS, Nagaprashantha L, Singhal P, Singhal S, Singhal J, Awasthi S, Horne D.

Pharm Res. 2017 Aug;34(8):1673-1682. doi: 10.1007/s11095-017-2154-y. Epub 2017 Apr 6. Review.

PMID:
28386633
5.

Novel compound 1,3-bis (3,5-dichlorophenyl) urea inhibits lung cancer progression.

Singhal SS, Figarola J, Singhal J, Nagaprashantha L, Berz D, Rahbar S, Awasthi S.

Biochem Pharmacol. 2013 Dec 15;86(12):1664-72. doi: 10.1016/j.bcp.2013.09.022. Epub 2013 Oct 4.

6.

Proteomic analysis of signaling network regulation in renal cell carcinomas with differential hypoxia-inducible factor-2α expression.

Nagaprashantha LD, Talamantes T, Singhal J, Guo J, Vatsyayan R, Rauniyar N, Awasthi S, Singhal SS, Prokai L.

PLoS One. 2013 Aug 5;8(8):e71654. doi: 10.1371/journal.pone.0071654. Print 2013.

7.

1,3-Bis(3,5-dichlorophenyl) urea compound 'COH-SR4' inhibits proliferation and activates apoptosis in melanoma.

Singhal SS, Figarola J, Singhal J, Leake K, Nagaprashantha L, Lincoln C, Gabriel Gugiu B, Horne D, Jove R, Awasthi S, Rahbar S.

Biochem Pharmacol. 2012 Dec 1;84(11):1419-27. doi: 10.1016/j.bcp.2012.08.020. Epub 2012 Aug 28.

8.

RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancer.

Leake K, Singhal J, Nagaprashantha LD, Awasthi S, Singhal SS.

PLoS One. 2012;7(4):e34582. doi: 10.1371/journal.pone.0034582. Epub 2012 Apr 3.

9.

Novel anti-cancer compounds for developing combinatorial therapies to target anoikis-resistant tumors.

Nagaprashantha L, Vartak N, Awasthi S, Awasthi S, Singhal SS.

Pharm Res. 2012 Mar;29(3):621-36. doi: 10.1007/s11095-011-0645-9. Epub 2011 Dec 28. Review.

PMID:
22203324
10.

Didymin induces apoptosis by inhibiting N-Myc and upregulating RKIP in neuroblastoma.

Singhal J, Nagaprashantha LD, Vatsyayan R, Ashutosh, Awasthi S, Singhal SS.

Cancer Prev Res (Phila). 2012 Mar;5(3):473-83. doi: 10.1158/1940-6207.CAPR-11-0318. Epub 2011 Dec 15.

11.

Nutlin-3 enhances sorafenib efficacy in renal cell carcinoma.

Vatsyayan R, Singhal J, Nagaprashantha LD, Awasthi S, Singhal SS.

Mol Carcinog. 2013 Jan;52(1):39-48. doi: 10.1002/mc.20875. Epub 2011 Oct 17.

12.

RLIP76, a glutathione-conjugate transporter, plays a major role in the pathogenesis of metabolic syndrome.

Singhal J, Nagaprashantha L, Vatsyayan R, Awasthi S, Singhal SS.

PLoS One. 2011;6(9):e24688. doi: 10.1371/journal.pone.0024688. Epub 2011 Sep 13.

13.

Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer.

Nagaprashantha LD, Vatsyayan R, Singhal J, Fast S, Roby R, Awasthi S, Singhal SS.

Biochem Pharmacol. 2011 Nov 1;82(9):1100-9. doi: 10.1016/j.bcp.2011.07.078. Epub 2011 Jul 23.

14.

Targeting p53-null neuroblastomas through RLIP76.

Singhal J, Yadav S, Nagaprashantha LD, Vatsyayan R, Singhal SS, Awasthi S.

Cancer Prev Res (Phila). 2011 Jun;4(6):879-89. doi: 10.1158/1940-6207.CAPR-11-0025. Epub 2011 Mar 16.

15.

2'-hydroxyflavanone inhibits proliferation, tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinoma.

Nagaprashantha LD, Vatsyayan R, Singhal J, Lelsani P, Prokai L, Awasthi S, Singhal SS.

Carcinogenesis. 2011 Apr;32(4):568-75. doi: 10.1093/carcin/bgr021. Epub 2011 Feb 8.

16.

The sensors and regulators of cell-matrix surveillance in anoikis resistance of tumors.

Nagaprashantha LD, Vatsyayan R, Lelsani PC, Awasthi S, Singhal SS.

Int J Cancer. 2011 Feb 15;128(4):743-52. doi: 10.1002/ijc.25725. Epub 2010 Dec 7. Review.

Supplemental Content

Loading ...
Support Center